Related Experiment Video
Updated: Apr 3, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Erratum to: Innate lymphoid cells in asthma phenotypes
Leyla Pur Ozyigit1, Hideaki Morita2, Mubeccel Akdis2
1Department of Allergy and Immunology, Koç University, School of Medicine, Istanbul, Turkey.
This study corrects a previous article DOI. The updated information ensures accurate citation and retrieval of scientific research findings.
Area of Science:
- Bibliometrics and scientific communication.
Context:
- Accurate citation is crucial for scientific integrity.
- Digital Object Identifiers (DOIs) are essential for locating research articles.
Purpose:
- To correct an erroneous article DOI.
- To ensure proper referencing and accessibility of the scientific record.
Summary:
- The article provides a correction to the Digital Object Identifier (DOI) for a previously published scientific work.
- This correction rectifies a citation error, ensuring readers can accurately access the intended research.
Impact:
- Improves the reliability of scientific literature.
- Facilitates accurate tracking and retrieval of research publications.
- Supports the integrity of academic referencing systems.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:

